CN104027457B - 一种增加个体血红素浓度的组合物 - Google Patents
一种增加个体血红素浓度的组合物 Download PDFInfo
- Publication number
- CN104027457B CN104027457B CN201410074798.4A CN201410074798A CN104027457B CN 104027457 B CN104027457 B CN 104027457B CN 201410074798 A CN201410074798 A CN 201410074798A CN 104027457 B CN104027457 B CN 104027457B
- Authority
- CN
- China
- Prior art keywords
- composition
- iron
- individual
- hemoglobin concentration
- ferrous iron
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 47
- 108010054147 Hemoglobins Proteins 0.000 title claims description 20
- 102000001554 Hemoglobins Human genes 0.000 title claims description 20
- 208000007502 anemia Diseases 0.000 claims abstract description 37
- 239000000284 extract Substances 0.000 claims abstract description 24
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 72
- 239000003814 drug Substances 0.000 claims description 41
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 claims description 38
- 239000004471 Glycine Substances 0.000 claims description 38
- 229940079593 drug Drugs 0.000 claims description 35
- 239000000843 powder Substances 0.000 claims description 15
- 241000405911 Rehmannia glutinosa Species 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 4
- 235000009508 confectionery Nutrition 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 150000001413 amino acids Chemical class 0.000 claims 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract description 69
- 229910052742 iron Inorganic materials 0.000 abstract description 35
- 239000000126 substance Substances 0.000 abstract description 6
- 230000001502 supplementing effect Effects 0.000 abstract description 6
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 abstract description 3
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 241000405414 Rehmannia Species 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract 3
- GIPOFCXYHMWROH-UHFFFAOYSA-L 2-aminoacetate;iron(2+) Chemical compound [Fe+2].NCC([O-])=O.NCC([O-])=O GIPOFCXYHMWROH-UHFFFAOYSA-L 0.000 abstract 2
- 208000005171 Dysmenorrhea Diseases 0.000 abstract 2
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000003278 haem Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 32
- 210000004369 blood Anatomy 0.000 description 20
- 239000008280 blood Substances 0.000 description 20
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 11
- 102000008857 Ferritin Human genes 0.000 description 10
- 108050000784 Ferritin Proteins 0.000 description 10
- 238000008416 Ferritin Methods 0.000 description 10
- 230000003821 menstrual periods Effects 0.000 description 10
- 206010022971 Iron Deficiencies Diseases 0.000 description 9
- 210000003743 erythrocyte Anatomy 0.000 description 9
- 235000013305 food Nutrition 0.000 description 9
- 241000700159 Rattus Species 0.000 description 7
- 239000013589 supplement Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 238000005534 hematocrit Methods 0.000 description 5
- 102000004338 Transferrin Human genes 0.000 description 4
- 108090000901 Transferrin Proteins 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000008929 regeneration Effects 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- 239000012581 transferrin Substances 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 229940126678 chinese medicines Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 235000003891 ferrous sulphate Nutrition 0.000 description 3
- 239000011790 ferrous sulphate Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical group [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 3
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 3
- 230000031700 light absorption Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 235000013405 beer Nutrition 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000010444 Acidosis Diseases 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 208000032467 Aplastic anaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 244000022372 Diospyros lotus Species 0.000 description 1
- 235000003333 Diospyros lotus Nutrition 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010021074 Hypoplastic anaemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010021703 Indifference Diseases 0.000 description 1
- 206010027417 Metabolic acidosis Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 208000031845 Pernicious anaemia Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000013626 chemical specie Substances 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 108700042971 cyanomethemoglobin Proteins 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 235000007144 ferric diphosphate Nutrition 0.000 description 1
- 239000011706 ferric diphosphate Substances 0.000 description 1
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 description 1
- 229940036404 ferric pyrophosphate Drugs 0.000 description 1
- 229910001448 ferrous ion Inorganic materials 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- 208000018875 hypoxemia Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- JEWJRMKHSMTXPP-BYFNXCQMSA-M methylcobalamin Chemical compound C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O JEWJRMKHSMTXPP-BYFNXCQMSA-M 0.000 description 1
- 235000007672 methylcobalamin Nutrition 0.000 description 1
- 239000011585 methylcobalamin Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 235000020989 red meat Nutrition 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (8)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2013100683649 | 2013-03-04 | ||
CN201310068364 | 2013-03-04 | ||
CN201310068364.9 | 2013-03-04 | ||
TW102133386A TWI694830B (zh) | 2013-03-04 | 2013-09-14 | 具相乘功效的治療貧血組成物 |
TW102133386 | 2013-09-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104027457A CN104027457A (zh) | 2014-09-10 |
CN104027457B true CN104027457B (zh) | 2019-07-16 |
Family
ID=51458602
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410074798.4A Active CN104027457B (zh) | 2013-03-04 | 2014-03-03 | 一种增加个体血红素浓度的组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104027457B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109432409A (zh) * | 2018-12-19 | 2019-03-08 | 上海康孕企业管理合伙企业(有限合伙) | 血红素在改善痛经的药物、食品及保健食品中的应用 |
CN111514211A (zh) * | 2020-06-01 | 2020-08-11 | 刘洋 | 一种用于治疗贫血的中药组合物 |
CN114699365A (zh) * | 2022-03-29 | 2022-07-05 | 广州白云山敬修堂药业股份有限公司 | 一种预防或改善贫血的补血膏滋及其制备方法和用途 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1428169A (zh) * | 2002-11-29 | 2003-07-09 | 吉泰安(四川)药业有限公司 | 补血养血纯中药制剂及其工艺方法和应用 |
CN101209102A (zh) * | 2006-12-30 | 2008-07-02 | 上海交大昂立股份有限公司 | 一种改善营养性贫血的功能性食品 |
-
2014
- 2014-03-03 CN CN201410074798.4A patent/CN104027457B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1428169A (zh) * | 2002-11-29 | 2003-07-09 | 吉泰安(四川)药业有限公司 | 补血养血纯中药制剂及其工艺方法和应用 |
CN101209102A (zh) * | 2006-12-30 | 2008-07-02 | 上海交大昂立股份有限公司 | 一种改善营养性贫血的功能性食品 |
Non-Patent Citations (2)
Title |
---|
汉方药补益作用的研究;贺玉琢;《国外医学中医中药分册》;19971031;第19卷(第5期);17-19 * |
铁补充剂的研究现状及展望;刘树立等;《中国食品添加剂》;20070215;第20卷(第01期);121-125 * |
Also Published As
Publication number | Publication date |
---|---|
CN104027457A (zh) | 2014-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104027457B (zh) | 一种增加个体血红素浓度的组合物 | |
CN106924406A (zh) | 一种用于治疗艾滋病的辅助用药的药物组合物及其制备方法 | |
US20170014467A1 (en) | Composition and the use thereof | |
CN102847159A (zh) | 一种葡萄糖新陈代谢增强剂 | |
CN107136504A (zh) | 一种抗氧化的功能性食品 | |
CN104042837B (zh) | 一种用于骨及骨关节退行性病变的药物组合物 | |
Schantz-Dunn et al. | Recognize and treat iron deficiency anemia in pregnant women | |
KR100624488B1 (ko) | 비만의 예방 및 치료용 조성물 | |
CN106237268B (zh) | 一种治疗精神分裂症的药物组合物及其应用 | |
CN108295187A (zh) | 提高免疫力的软胶囊制剂及其制备方法 | |
KR102180165B1 (ko) | 빈혈을 치료하기 위한 공동상승작용 조성물 | |
TW201434473A (zh) | 具相乘功效的治療貧血組成物 | |
CN105816470A (zh) | 20(R)-人参皂苷Rg3在制备缓解或/和治疗糖尿病药物或保健品中的应用及药物 | |
CN117530437A (zh) | 一种具有防治酒精性肝损伤的药食两用组合物及其制备方法与应用 | |
CN102579713A (zh) | 治疗儿童肥胖症的中药及制备方法 | |
CN106334039A (zh) | 一种治疗糖尿病肾病的中药复方制剂及其制备方法 | |
CN101293024A (zh) | 用于预防出生缺陷并改善记忆和智力的药物组合物 | |
CN101375908A (zh) | 用于预防出生缺陷与改善记忆和智力的药物组合物 | |
CN101293050A (zh) | 用于预防出生缺陷并改善记忆的药物组合物 | |
CN101417010A (zh) | 用于预防出生缺陷及改善记忆的药物组合物 | |
CN101288698A (zh) | 用于预防出生缺陷及改善记忆的药物组合物 | |
CN101417012A (zh) | 用于预防出生缺陷及改善记忆的药物组合物 | |
CN101293022A (zh) | 用于预防出生缺陷及改善记忆的药物组合物 | |
CN104587280A (zh) | 一种治疗婴幼儿佝偻病的药剂 | |
CN101288717A (zh) | 用于预防出生缺陷并改善记忆的药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1198633 Country of ref document: HK |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20190620 Address after: 1188 Guangxing Road, Songjiang District, Shanghai Applicant after: Zhongtian (Shanghai) Biotechnology Co., Ltd. Address before: Taipei City, Taiwan, China Applicant before: Zhongtian Biological Science &. Technology Co., Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1198633 Country of ref document: HK |